Brief: Bicycle Therapeutics PLC Announces Expansion Of Genentech Immuno-Oncology Collaboration
Oct 26 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS ANNOUNCES EXPANSION OF GENENTECH
IMMUNO-ONCOLOGY COLLABORATION
* BICYCLE THERAPEUTICS PLC - GENENTECH EXERCISED AN OPTION
TO
INITIATE AN ADDITIONAL PROGRAM UNDER 2020 COLLABORATION
AGREEMENT
Source text for Eikon: ID:nBw5TRP9ga
Further company coverage: BCYC.O
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics PLC reports results for the quarter ended September 30 - Earnings Summary
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
Bicycle Therapeutics PLC expected to post a loss of 43 cents a share - Earnings Preview
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
Bicycle Therapeutics Q1 revenue drops after partnership terminations